Whilst we observed exon skipping of exon 6 of MDM4 mRNA in neuroblastoma cell lines too, our GSK3203591 sensitivity spectrum suggests that p53 activation is not the major determinant of drug sensitivity in MNA neuroblastoma. The gene discussed is MDM4; the disease is neuroblastoma.